Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Aug 2024 for Agile Therapeutics INC, €1,329.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John W. Hubbard: trading record in brief
This profile gathers the share dealings of John W. Hubbard across 2 companies, led by Agile Therapeutics Inc and Science 37 Holdings, Inc. The record holds 8 filings, for trades running from 8 June 2018 to 26 August 2024.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 26 August 2024: a transaction of €1,329, in Agile Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John W. Hubbard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
976 shares@ US$1.52100.0% of flowCommon StockSEC:0001104659-24-092933:0
2,050 shares@ US$5.75100.0% of flowCommon StockSEC:0001819113-24-000016:0
935 shares0Common StockSEC:0000929638-23-001710:0
40,983 shares0Common StockSEC:0001819113-23-000045:0
670 shares0Common StockSEC:0001104659-22-070178:0
24,510 shares0Common StockSEC:0001104659-21-079620:0
6 of 6 declarations
